Scientific Program
MAFLD Symposium Chairs: Carlo Cornejo, Angelo Lozada |
|
8:00AM – 8:20AM | Case identification of MAFLD outside liver clinics: How and who needs to be referred? Speaker: Soek Siam Tan, Selangor |
8:20AM – 8:40AM | Non-invasive staging and monitoring of MAFLD Speaker: Han Chieh Lin, Taipei |
8:40AM – 9:00AM | Updates on the management of MAFLD Speaker: Janus Ong, Manila |
9:00AM – 9:15AM | Q&A |
9:15AM – 9:30AM | Coffee Break |
Management and Prevention Strategies in the Cirrhotic Patient I Chairs: Arlinking Ong-Go, Karen Estelle de Lunas |
|
9:30AM – 9:50AM | Management of the common symptoms of muscle cramps, pruritus, and insomnia in patients with cirrhosis Speaker: Rino Gani, Jakarta |
9:50AM – 10:10AM | Management of ascites in patients with cirrhosis Speaker: Jenny Limquiaco, Cebu |
10:10AM – 10:30AM | Optimal management of the metabolic conditions in the cirrhotic patient Speaker: Grace Wong, Hong Kong |
10:30AM – 10:45AM | Q&A |
Management and Prevention Strategies in the Cirrhotic Patient II Chairs: Roberto De Guzman, Jr, Rommel Romano |
|
10:45AM – 11:15AM | Surveillance strategies in the patient with cirrhosis – gastroesophageal varices and hepatocellular carcinoma Speaker: Madalinee Eternity Labio, Manila |
11:15AM – 11:35AM | Hepatoprotectants and rational drug use in cirrhotics Speaker: Rosmawati Mohamed, Kuala Lumpur |
11:35AM – 11:55AM | Health maintenance of the cirrhotic patient – nutrition counseling and vaccinations Speaker: Mara Teresa Panlilio, Manila |
11:55AM – 12:10PM | Q&A |
12:10PM – 1:40PM | Lunch |
Endoscopy in Hepatology Chairs: Frederick Dy, Allyn Rey Lomboy |
|
1:40PM – 2:00PM | Perioprocedural care of the cirrhotic patient for endoscopy Speaker: Arlinking Ong-Go, Manila |
2:00PM – 2:20PM | Endohepatology: Role of EUS in Liver Diseases Speaker: Yu Jun Wong, Singapore |
2:20PM – 2:40PM | Updates on the endoscopic management of portal hypertension and its complications: Beyond banding and glue Speaker: Mark Anthony De Lusong, Manila |
2:40PM – 2:55PM | Q&A |
2:55PM – 3:10PM | Coffee Break |
Diagnosis and Evaluation of Patients with Cirrhosis Chairs: Joseph Bocobo, Danny Joseph Tuazon |
|
3:10PM – 3:30PM | Non-invasive tools for cACLD and clinically significant portal hypertension Speaker: Juan Carlos Garcia-Pagan, Barcelona |
3:30PM – 3:50PM | Hepatic venography, hepatic hemodynamics, and transjugular biopsy: An overview Speaker: Ramon Santos-Ocampo, Manila |
3:50PM – 4:10PM | Pre-operative risk assessment of patients with cirrhosis Speaker: Lawrence Chad Liu, Cebu |
4:10PM – 4:25PM | Q&A |
PLENARY HALL A | PLENARY HALL B | |
---|---|---|
Symposium: Epidemiology and Outcomes Chairs: Judy Lao-Tan, Michelle Ong-Chu |
Symposium: Infections in cirrhosis Chairs: Benjamin Perez, Jr, Jose Guillain Cataluña |
|
8:00AM – 8:20AM | Epidemiology of cirrhosis in Asia-Pacific Speaker: Jose Sollano, Jr, Manila |
Management of spontaneous bacterial peritonitis Speaker: Juliet Cervantes, Manila |
8:20AM – 8:40AM | Natural history of cirrhosis Speaker: Rino Gani, Jakarta |
The changing landscape of bacterial infections in cirrhosis Speaker: Jidong Jia, Beijing |
8:40AM – 9:00AM | Patient reported outcomes in patients with cirrhosis Speaker: Soek Siam Tan, Selangor |
Antibiotics in patients with cirrhosis: prophylaxis and use Speaker: Cybele Lara Abad, Manila |
9:00AM – 9:15AM | Q&A | |
9:15AM – 9:30AM | Coffee Break | |
9:30AM – 10:00AM | OPENING CEREMONIES | |
10:00AM – 10:30AM | STATE OF THE ART LECTURE I Artificial Intelligence in Hepatology Chair: Denis Ngo Speaker: Tung-Hung Su, Taipei |
|
Symposium: Viral Hepatitis-related Cirrhosis Chairs: Ira Yu, Jennielyn Agcaoili-Conde |
Symposium: Ascites, Refractory Ascites, and HRS Chairs: Marie Michelle Cloa, Angelo Jonathan Cruz |
|
10:30AM – 10:50AM | Predictive risk scores for cirrhosis and hepatocellular carcinoma in Hepatitis B Speaker: Grace Wong, Hong Kong |
Rational use of albumin in patients with cirrhosis Speaker: Ki Tae Suk, Gangwon |
10:50AM – 11:10AM | Management of the Hepatitis C-related cirrhosis patient after SVR Speaker: Masao Omata, Tokyo |
Optimal management of refractory ascites in 2023 Speaker: Edhel Tripon, Manila |
11:10AM – 11:30AM | Impact of MAFLD and the Metabolic Syndrome on Viral Hepatitis Speaker: Tung-Hung Su, Taipei |
Advances in the management of HRS-AKI Speaker: Ian Homer Cua, Manila |
11:30AM – 11:45AM | Q&A | |
11:45AM – 1:15PM | Lunch Symposium (Helande): Utility of Double Plasma Molecular Adsorption System in Liver Disease Moderator: Ian Homer Cua Speaker: Rakhi Maiwall |
|
1:15PM – 2:15PM | Free Paper Presentation | |
2:15PM – 2:45PM | STATE OF THE ART LECTURE II Liver Fibrosis: Therapeutic Targets and Drug Development Chair: Ian Homer Cua Speaker: Jordi Gracia-Sancho, Barcelona |
|
2:45PM – 3:00PM | Coffee Break | |
Symposium: Portal hypertension I Chairs: Patricia Ann Prodigalidad, Vanessa Tanco |
Symposium: Hepatic Encephalopathy Chairs: Jade Jamias, Peter Andrew Reyes |
|
3:00PM – 3:20PM | Emerging therapies in portal hypertension: Beyond NSBB Speaker: Jaime Bosch, Bern |
Minimal hepatic encephalopathy: Recognition and management Speaker: Angela Salvaña, Manila |
3:20PM – 3:40PM | Cirrhosis Recompensation: Predictors and Natural History Speaker: Stephen Wong, Manila |
Approach to hepatic encephalopathy and brain edema in ACLF Speaker: Rajiv Jalan, London |
3:40PM – 4:00PM | Role of NSBB in patients with cirrhosis and portal hypertension in 2023 Speaker: James Fung, Hong Kong |
The gut microbiome and its manipulation in HE Speaker: Ki Tae Suk, Gangwon |
4:00PM – 4:15PM | Q&A | |
Symposium: Clinical Debates Chairs: Albert Ismael, Marie Ellaine Velasquez |
Symposium: Coagulation in Cirrhosis Chairs: Wendell Espinosa, Suzette Kho-Herman |
|
4:15PM – 4:35PM | Portal Vein Thrombosis in Cirrhosis: Anticoagulate or Not? Speakers: Tawesak Tanwandee, Bangkok Jose Sollano, Jr, Manila |
Tranfusion strategies in patients with cirrhosis Speaker: Lynn Bonifacio, Manila |
4:35PM – 4:55PM | Antiplatelet and anticoagulant use in patients with cirrhosis Speaker: Manoj Kumar Sharma, New Delhi |
|
4:55PM – 5:15PM | Outpatient albumin infusions in patients with cirrhosis: To Give or Not to Give? Speakers: George Lau, Hong Kong Diana Payawal, Manila |
Assessment of hemostasis in patients with endstage liver disease Speaker: Alma Reyes-Calavera, Manila |
5:15PM – 5:30PM | Q&A |
PLENARY HALL A | PLENARY HALL B | |
---|---|---|
Symposium: Acute on Chronic Liver Failure I Chairs: Hilda Dina Gonzales, Edhel Tripon |
Symposium: Hepatocellular Carcinoma Chairs: Juliet Cervantes, Stephen Wong |
|
8:00AM – 8:20AM | Drug-induced liver injury associated ACLF Speaker: Diana Payawal, Manila |
Ablation for HCC in Cirrhosis: Current Concepts and Limitations Speaker: Shuichiro Shiina, Tokyo |
8:20AM – 8:40AM | HBV flare-associated ACLF Speaker: George Lau, Hong Kong |
Combination locoregional and systemic therapy in HCC: The evolving landscape Speaker: Brian Goh, Singapore |
8:40AM – 9:00AM | Alcoholic hepatitis-associated ACLF Speaker: Rajiv Jalan, London |
Systemic therapies for HCC in cirrhosis: Expanding and redefining treatment approaches Speaker: Masatoshi Kudo, Osaka |
9:00AM – 9:15AM | Q&A | |
9:15AM – 9:30AM | Coffee Break | |
9:30AM – 10:00AM | STATE OF THE ART LECTURE III ACLF in Asia Chair: Jose Sollano, Jr Speaker: Shiv Kumar Sarin, New Delhi |
|
Symposium: Acute on Chronic Liver Failure II Chair: Lawrence Chad Liu, Karla Nomorosa-Suzara |
Symposium: Liver Transplantation Chair: Vanessa De Villa, Yvonne Mina |
|
10:00AM – 10:20AM | Controversies and Evolving Concepts on Liver Support Systems in ACLF Speaker: Manoj Kumar Sharma, New Delhi |
Liver transplantation for severe alcoholic hepatitis Speaker: Mark Muthiah, Singapore |
10:20AM – 10:40AM | Prognostication in ACLF Speaker: Qin Ning, Wuhan |
Downstaging of HCC to liver transplantation in 2023 Speaker: Masatoshi Kudo, Osaka |
10:40AM – 11:00AM | Intensive Care Management of Acute-on-Chronic Liver Failure Speaker: Avik Majumdar, Melbourne |
Liver transplantion for acute on chronic liver failure Speaker: James Fung, Hong Kong |
11:00AM – 11:15AM | Q&A | |
11:15AM – 12:45PM | Lunch Symposium (Roche): A New Era for Hepatocellular Carcinoma Moderator: Andrea Monica Talag-Espinosa Speakers: Janus Ong, Chiun Hsu, Stephen Wong, Daniel Cigoianu |
|
12:45PM – 1:45PM | Free Paper Presentation | |
1:45PM – 2:15PM | STATE OF THE ART LECTURE IV Updates from Baveno VII Chair: Diana Payawal Speaker: Jaime Bosch, Bern |
|
Symposium: Vascular Diseases Chairs: Jenny Limquiaco, Therese Macatula |
Symposium: Nutrition and Frailty in Cirrhosis Chairs: Maria Blanca Kua, Ruter Maralit |
|
2:15PM – 2:35PM | Portosinusoidal vascular disorder: recognition, diagnosis, management Speaker: Rakhi Maiwall, New Delhi |
Sarcopenia and Frailty in Cirrhosis: Recognition and Management Speaker: Jade Jamias, Manila |
2:35PM – 2:55PM | Therapeutic Challenges in Non-cirrhotic, Non-malignant Extrahepatic Portal Vein Thrombosis Speaker: Juan Carlos Garcia-Pagan, Barcelona |
Optimizing nutrition in the failing cirrhotic on the liver transplant list Speaker: Geraldine Claire Floro-Lucero, Manila |
2:55PM – 3:15PM | Budd-Chiari Syndrome: Recognition and management Speaker: Jidong Jia, Beijing |
Non-hospice palliative care in end stage liver disease Speaker: Avik Majumdar, Melbourne |
3:15PM – 3:30PM | Q&A | |
3:30PM – 3:45PM | Coffee Break | |
Symposium: Portal hypertension II Chairs: Allan Policarpio, Angela Salvaña |
Symposium: The Heart and Lung in Cirrhosis Chairs: Ma. Carla Sibulo, Lovell Gatchalian |
|
3:45PM – 4:05PM | Management of Gastric Varices: BRTO, CARTO, or PARTO Speaker: Cicero Matthew Habito, Manila |
Hepatopulmonary syndrome Speaker: Mark Muthiah, Singapore |
4:05PM – 4:25PM | Applications of TIPS in complications of portal hypertension Speaker: Yu Jun Wong, Singapore |
Portopulmonary hypertension Speaker: Gene Philip Louie Ambrocio, Manila |
4:25PM – 4:45PM | Is there a role for surgical management of portal hypertension in 2023? Speaker: Brian Goh, Singapore |
Cirrhotic cardiomyopathy Speaker: Jose Donato Magno, Manila |
4:45PM – 5:00PM | Q&A | |
5:00PM | CLOSING CEREMONIES |